Brief: Sequana Medical Announces Strong Interim Results From RED DESERT Alfapump® DSR Study

Sequana Medical NV

22/10/2020 06:23

Oct 22 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * SEQUANA MEDICAL ANNOUNCES STRONG INTERIM RESULTS FROM RED
DESERT
ALFAPUMP® DSR STUDY AND PROVIDES BUSINESS UPDATE
    * RESULTS FROM FIRST FIVE PATIENTS INDICATE REPEATED DOSE
ALFAPUMP
DSR THERAPY TO BE SAFE AND EFFECTIVE
    * INTERIM DATA SUPPORT DSR HYPOTHESIS: KIDNEYS ELIMINATE
FREE
WATER TO MAINTAIN PATIENTS' SERUM SODIUM LEVELS
    * NO PATIENTS REQUIRED LOOP DIURETIC THERAPY DURING SIX-WEEK
ALFAPUMP DSR TREATMENT PERIOD
    * FULL RED DESERT DATA ON TRACK TO REPORTIN H1 2021
    * FIRST FEASIBILITY STUDY (SAHARA DESERT) PLANNED TO START
IN H1
2021

Source text for Eikon:  ID:nGNX2xBYvB 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))